ACVR1 anticorps (AA 20-125)
-
- Antigène Voir toutes ACVR1 (ACRV1) Anticorps
- ACVR1 (ACRV1) (Activin Receptor Type I (ACRV1))
-
Épitope
- AA 20-125
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ACVR1 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- SMEDEKPKVN PKLYMCVCEG LSCGNEDHCE GQQCFSSLSI NDGFHVYQKG CFQVYEQGKM TCKTPPSPGQ AVECCQGDWC NRNITAQLPT KGKSFPGTQN FHLEVG
- Réactivité croisée
- Humain, Souris
- Attributs du produit
- Polyclonal Antibodies
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 20-125 of human ACVR1 (NP_001096.1).
- Isotype
- IgG
- Top Product
- Discover our top product ACRV1 Anticorps primaire
-
-
- Indications d'application
- WB,1:500 - 1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- ACVR1 (ACRV1) (Activin Receptor Type I (ACRV1))
- Autre désignation
- ACVR1 (ACRV1 Produits)
- Synonymes
- anticorps ACTRI, anticorps ACVR1A, anticorps ACVRLK2, anticorps ALK2, anticorps FOP, anticorps SKR1, anticorps TSRI, anticorps ActR-IA, anticorps ActR-I, anticorps ActRIA, anticorps Acvr, anticorps Acvrlk2, anticorps Alk-2, anticorps Alk8, anticorps D330013D15Rik, anticorps Tsk7L, anticorps actri, anticorps acvr1, anticorps acvr1-a, anticorps acvr1-b, anticorps acvr1a, anticorps acvrlk2, anticorps alk-2, anticorps alk2, anticorps alk8, anticorps fop, anticorps sax, anticorps skr1, anticorps tsri, anticorps xALK-2, anticorps activin A receptor type 1, anticorps activin A receptor, type 1, anticorps activin A receptor type 1 S homeolog, anticorps ACVR1, anticorps Acvr1, anticorps acvr1.S
- Sujet
- Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive.,ACVR1,ACTRI,ACVR1A,ACVRLK2,ALK2,FOP,SKR1,TSRI,Epigenetics & Nuclear Signaling,Signal Transduction,Kinase,Cell Biology & Developmental Biology,Apoptosis,Cytoskeleton,Microfilaments,Extracellular Matrix,Bone,Stem Cells,Cardiovascular,Angiogenesis,ACVR1
- Poids moléculaire
- 57 kDa
- ID gène
- 90
- UniProt
- Q04771
-